Biotech veteran Brian O’Callaghan introduces ObsEva – a Swiss-based firm focused on women’s health –, his motivations to join the company – which is on the verge of transforming into a commercial-stage outfit –, and the strategy he has put in place moving forward. O’Callaghan also shares his insights on the Swiss biotech innovation ecosystem’s progress at large and the challenges of taking on a new CEO role in the midst of a pandemic.
There are very few treatment options available to women and they, therefore, need and deserve new and more innovative treatment options
